Amicus Therapeutics Stock Price - FOLD

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 8.25 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Amicus Therapeutics Inc FOLD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.31 3.9% 8.25 8.29 7.92 7.93 7.94 18:01:23
Bid Price Ask Price Spread Spread % News
7.50 9.60 2.10 21.87% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
14,450 2,683,092 $ 8.19 $ 21,980,533 4,495,082 7.11 - 14.72
Last Trade Time Type Quantity Stock Price Currency
17:13:08 formt 122,687 $ 8.25 USD

Amicus Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.10B 254.63M $ -349.00M -1.86 - 251.67M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Amicus Therapeutics News

Loading Messages....

Latest FOLD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FOLD Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week7.688.297.417.70944M0.577.42%
1 Month9.769.97.118.29334M-1.51-15.47%
3 Months12.8112.99017.119.54833M-4.56-35.60%
6 Months13.8114.297.1110.96423M-5.56-40.26%
1 Year12.3114.727.1111.28703M-4.06-32.98%
3 Years6.917.624.4111.46103M1.3519.57%
5 Years5.2218.834.4110.62183M3.0358.05%

Amicus Therapeutics Description

Amicus Therapeutics Inc is a global biotechnology company that aims to treat rare and orphan diseases. The company's strategy focuses on global capacity with an international infrastructure, late-stage product acquisition, and biologics manufacturing. Amicus leverages its pharmacological technology to develop treatments for human genetic diseases by targeting mutated proteins. The company utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products.

Your Recent History
Amicus The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.